为冠心病患者提供数字化心脏康复计划的成本效益
在PubMed上查看摘要
概括
此摘要是机器生成的。数字化心脏康复 (DeCR) 是冠状动脉疾病患者的成本效益高的策略,改善了健康结果. 这种数字化方法提供了与常规护理相比更好的质量调整寿命 (QALYs).
科学领域
- 心血管医学
- 健康经济学
- 数字健康
背景情况
- 冠心病需要有效且易于获得的康复计划.
- 传统的心脏康复可能有所限制.
- 数字化心脏康复 (DeCR) 为广泛患者提供了潜在的解决方案.
研究的目的
- 评估国家实施的对心脏病患者的DeCR计划的长期成本效益.
- 为了比较DeCR与常规护理的健康结果和成本.
主要方法
- 使用马尔科夫模型进行了成本效益分析.
- 收集了住院费用和干预措施的数据.
- 经质量调整的寿命年 (QALYs) 是从EQ-5D-5L得分和文献估计得出的.
- 采用了5%的每年折扣的五年时间.
- 敏感性分析的支付值为每QALY5万澳元.
主要成果
- 德克尔获得了4.677个QALY,价格为121,235澳元,而常规护理则为3.244个QALY,价格为100,733澳元.
- 增加的成本效益比率 (ICER) 为14,302澳元/QALY,低于WTP门.
- 在87%的模拟中发现DeCR具有成本效益.
结论
- 数字化心脏康复是心脏病患者常规护理的经济有效替代方案.
- 在可接受的经济成本下,DeCR改善了健康结果,包括QALY.
- 这些发现支持更广泛地实施DeCR计划.
相关概念视频
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...

